Portal hypertensive gastropathy and gastric antral vascular ectasia
- PMID: 26376475
- DOI: 10.1097/MOG.0000000000000214
Portal hypertensive gastropathy and gastric antral vascular ectasia
Abstract
Purpose of review: Portal hypertensive gastropathy (PHG) and gastric antral vascular ectasia (GAVE) are two types of upper gastrointestinal bleeding that may present similarly, but are managed very differently. This article reviews the pathogenesis and guidelines in management of both of these conditions with emphasis on recent advances in the field.
Recent findings: Off-label use of Hemospray has been shown in several case series to be useful in managing acute bleeding from PHG. Balloon-occluded retrograde transvenous obliteration presents an alternative approach for this condition. Radiofrequency ablation may be an alternative therapy to argon plasma coagulation in the endoscopic treatment of GAVE, as it consists of fewer sessions and has been shown to decrease gastrointestinal blood loss.
Summary: The treatment options for PHG and GAVE are constantly evolving and expanding. In this review, we present the latest approaches in the gastroenterologist's arsenal to deal with these conditions.
Similar articles
-
Approach to the management of portal hypertensive gastropathy and gastric antral vascular ectasia.Gastroenterol Clin North Am. 2014 Dec;43(4):835-47. doi: 10.1016/j.gtc.2014.08.012. Epub 2014 Sep 20. Gastroenterol Clin North Am. 2014. PMID: 25440929 Review.
-
Review article: the management of portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis.Aliment Pharmacol Ther. 2014 Aug;40(4):354-62. doi: 10.1111/apt.12824. Epub 2014 Jun 2. Aliment Pharmacol Ther. 2014. PMID: 24889902 Review.
-
Portal hypertensive gastropathy and gastric antral vascular ectasia.Indian J Gastroenterol. 2015 Sep;34(5):351-8. doi: 10.1007/s12664-015-0605-0. Epub 2015 Nov 13. Indian J Gastroenterol. 2015. PMID: 26564121 Review.
-
Role of Endoscopy in the Diagnosis, Grading, and Treatment of Portal Hypertensive Gastropathy and Gastric Antral Vascular Ectasia.Gastrointest Endosc Clin N Am. 2024 Apr;34(2):263-274. doi: 10.1016/j.giec.2023.09.013. Epub 2023 Oct 29. Gastrointest Endosc Clin N Am. 2024. PMID: 38395483 Review.
-
The management of portal hypertensive gastropathy and gastric antral vascular ectasia.Dig Liver Dis. 2011 May;43(5):345-51. doi: 10.1016/j.dld.2010.10.006. Epub 2010 Nov 20. Dig Liver Dis. 2011. PMID: 21095166 Review.
Cited by
-
IL-6-driven FasL promotes NF-κBp65/PUMA-mediated apoptosis in portal hypertensive gastropathy.Cell Death Dis. 2019 Oct 3;10(10):748. doi: 10.1038/s41419-019-1954-x. Cell Death Dis. 2019. PMID: 31582729 Free PMC article.
-
PGE2 /EP4 receptor attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated proliferation in portal hypertensive gastropathy.Br J Pharmacol. 2017 May;174(9):848-866. doi: 10.1111/bph.13752. Epub 2017 Mar 25. Br J Pharmacol. 2017. PMID: 28213942 Free PMC article.
-
Nitrous oxide cryotherapy ablation for refractory gastric antral vascular ectasia.United European Gastroenterol J. 2018 Oct;6(8):1155-1160. doi: 10.1177/2050640618783537. Epub 2018 Jun 12. United European Gastroenterol J. 2018. PMID: 30288277 Free PMC article.
-
Managing Acute Portal Hypertensive Gastropathy Bleed During the Time of COVID-19 Pandemic: Novelty or Necessity?Cureus. 2020 May 28;12(5):e8333. doi: 10.7759/cureus.8333. Cureus. 2020. PMID: 32489751 Free PMC article.
-
Comparison of portal hypertensive gastropathy and gastric antral vascular ectasia: an update.Gastroenterol Hepatol Bed Bench. 2022 Summer;15(3):204-218. doi: 10.22037/ghfbb.v15i3.2561. Gastroenterol Hepatol Bed Bench. 2022. PMID: 36311963 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials